FDA, CDC opens investigation into cronobacter and salmonella complaints in infant formula
The US Food and Drug Administration (FDA) and CDC (Centers for Disease Control and Prevention) are looking into 4 complaints about illness linked to Abbott Nutrition formula produced in a Michigan factory.
The US Food and Drug Administration has started an inspection of the Sturgis, Michigan Abbott Nutrition plant that manufactured powedered infant formula that has been linked to 3 reports of Cronobacter sakazakii infections and 1 report of Salmonella Newport infection in infants.1 All of the infants required hospitalization and 1 died.
The findings found so far include multiple positive C sakazakii results from samples. A review of records showed potential environmental contamination from C sakazakii as well as product that had been destroyed because of the presence of the bacteria.
Abbott Nutrition started a voluntary recall of the formula yesterday, February 17, 2022. The affected products are Similac, Alimentum, or EleCare with the following information that can be found on the bottom:
- the first two digits of the code are 22 through 37 and
- the code on the container contains K8, SH, or Z2, and
- the expiration date is 4-1-2022 (APR 2022) or later.
Reference
1. US Food and Drug Administration. FDA investigation of Cronobacter and Salmonella complaints: powdered infant formula. Published February 18, 2022. Accessed February 18, 2022. https://www.fda.gov/food/outbreaks-foodborne-illness/fda-investigation-cronobacter-and-salmonella-complaints-powdered-infant-formula-february-2022
The benefits of concurrent fetal and maternal heart rate monitoring
April 17th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
